Cargando…

The role of RNA modification in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a highly mortal type of primary liver cancer. Abnormal epigenetic modifications are present in HCC, and RNA modification is dynamic and reversible and is a key post-transcriptional regulator. With the in-depth study of post-transcriptional modifications, RNA modific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Qiang, Wang, Dongxu, Xue, Tianyi, Lin, Chao, Gao, Yongjian, Sun, Liqun, Jin, Ye, Liu, Dianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479111/ https://www.ncbi.nlm.nih.gov/pubmed/36120301 http://dx.doi.org/10.3389/fphar.2022.984453

Ejemplares similares

The Role and Application of Exosomes in Gastric and Colorectal Cancer
por: Li, Qirong, et al.
Publicado: (2022)

Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022)

Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
por: Feng, Qiang, et al.
Publicado: (2022)

Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
por: Li, Chengshun, et al.
Publicado: (2022)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Huo, Xing-xing, et al.
Publicado: (2021)

Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma
por: Yang, Lei, et al.
Publicado: (2023)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system
por: Wang, Qiaona, et al.
Publicado: (2023)

The Biology and Function of Extracellular Vesicles in Cancer Development
por: Zhang, Xinyi, et al.
Publicado: (2021)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
por: Zhao, Kun, et al.
Publicado: (2022)

Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
por: Xiao, Chunying, et al.
Publicado: (2023)

The role of major immune cells in myocardial infarction
por: Feng, Qiang, et al.
Publicado: (2023)

Research Progress of RNA Methylation Modification in Colorectal Cancer
por: Liang, Weizheng, et al.
Publicado: (2022)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
por: Yao, Man, et al.
Publicado: (2023)

The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma
por: An, Yang, et al.
Publicado: (2020)

Galangin promotes cell apoptosis through suppression of H19 expression in hepatocellular carcinoma cells
por: Zhong, Xiaowei, et al.
Publicado: (2020)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
por: Shi, Chuan-jian, et al.
Publicado: (2021)

Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
por: Feng, Yingqi, et al.
Publicado: (2022)

Computational and In Vitro Analysis of Plumbagin’s Molecular Mechanism for the Treatment of Hepatocellular Carcinoma
por: Wei, Yanfei, et al.
Publicado: (2021)

The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma
por: Ghionescu, Alina-Veronica, et al.
Publicado: (2023)

Roles of m(6)A modification in oral cancer (Review)
por: Liu, Huimin, et al.
Publicado: (2022)

Dioscorea Zingiberensis New Saponin Inhibits the Growth of Hepatocellular Carcinoma by Suppressing the Expression of Long Non-coding RNA TCONS-00026762
por: Liu, Xing, et al.
Publicado: (2021)

Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases
por: Li, Yun, et al.
Publicado: (2022)

Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
por: Xue, Zhong, et al.
Publicado: (2023)

Activation of FcRn Mediates a Primary Resistance Response to Sorafenib in Hepatocellular Carcinoma by Single-Cell RNA Sequencing
por: Guan, Xin, et al.
Publicado: (2021)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
por: Hu, Xue, et al.
Publicado: (2021)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
por: Hu, Xue, et al.
Publicado: (2022)

Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Jin, Yong, et al.
Publicado: (2021)

Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
por: Sun, Hang, et al.
Publicado: (2023)

Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma
por: Lai, Shih-Wei, et al.
Publicado: (2017)

Systematic analysis of the role and significance of target genes of active ingredients of traditional Chinese medicine injections in the progression and immune microenvironment of hepatocellular carcinoma
por: Wang, Chao, et al.
Publicado: (2023)

Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis
por: Gao, Tianqi, et al.
Publicado: (2023)

Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification
por: Huang, Yongye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7sda8ckfu9bv1gjcu2h85mhqr1